BURNABY, British Columbia, March 22, 2023 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the virtual Stifel 2023 CNS Days taking place March 28-29, 2023. Company Fireside Chat Presentation Details: Date:Tuesday, March 28, 2023 Time:1:00 pm Eastern Time (10:00 am Pacific Time) Presenters:Ian Mortimer, President and CEO Sherry Aulin, CFO Webcast: Link to pre-register for the webcast can b
Xenon Pharmaceuticals ( NASDAQ:XENE ) Full Year 2022 Results Key Financial Results Net loss: US$124.9m (loss widened by...
Just because a business does not make any money, does not mean that the stock will go down. For example, although...